Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity

Abstract Background Expression of the urokinase plasminogen activator receptor (uPAR) is elevated in the airway epithelium in asthma; however, the contribution of uPAR to asthma pathogenesis and scope for therapeutic targeting remains unknown. Objectives To determine (i) the expression profile of uP...

Full description

Bibliographic Details
Main Authors: Michael A. Portelli, Sangita Bhaker, Vincent Pang, David O. Bates, Simon R. Johnson, Andrew P. Mazar, Dominick Shaw, Christopher Brightling, Ian Sayers
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Clinical and Translational Allergy
Subjects:
Online Access:https://doi.org/10.1002/clt2.12293
_version_ 1797650781906665472
author Michael A. Portelli
Sangita Bhaker
Vincent Pang
David O. Bates
Simon R. Johnson
Andrew P. Mazar
Dominick Shaw
Christopher Brightling
Ian Sayers
author_facet Michael A. Portelli
Sangita Bhaker
Vincent Pang
David O. Bates
Simon R. Johnson
Andrew P. Mazar
Dominick Shaw
Christopher Brightling
Ian Sayers
author_sort Michael A. Portelli
collection DOAJ
description Abstract Background Expression of the urokinase plasminogen activator receptor (uPAR) is elevated in the airway epithelium in asthma; however, the contribution of uPAR to asthma pathogenesis and scope for therapeutic targeting remains unknown. Objectives To determine (i) the expression profile of uPAR in cultured human bronchial epithelial cells (HBEC) from asthma patients, (ii) the relationship between uPAR and the epithelial barrier, including blocking uPAR functions and (iii) the function of different uPAR isoforms. Methods uPAR levels in HBECs isolated from asthma patients and cells at air liquid interface (ALI) during differentiation were quantified. Transepithelial electrical resistance or electrical cell impedance sensing was used to relate uPAR levels to barrier properties, including effects of uPAR blocking antibodies. The functional effects of gain of function was determined using transcriptomics, in cells over‐expressing membrane (muPAR), soluble cleaved (scuPAR) or soluble spliced (ssuPAR) isoforms. Results Elevated expression of uPAR was a feature of cultured HBECs from asthma patients, suggesting intrinsic alterations in asthma patient cells. Soluble uPAR levels inversely correlated with barrier properties of the HBEC layer in 2D and ALI. Blocking uPAR‐integrin interactions enhanced barrier formation. The gain of function cells showed limited transcriptomic changes. Conclusion This study provides a significant advance in our understanding of the relationship between asthma, uPAR and the epithelial barrier, where elevated circulating uPAR results in a reduced cell barrier, a phenotype prevalent in asthma.
first_indexed 2024-03-11T16:05:25Z
format Article
id doaj.art-b98b2138b6a345bba5e4c156f9115f19
institution Directory Open Access Journal
issn 2045-7022
language English
last_indexed 2024-03-11T16:05:25Z
publishDate 2023-10-01
publisher Wiley
record_format Article
series Clinical and Translational Allergy
spelling doaj.art-b98b2138b6a345bba5e4c156f9115f192023-10-25T03:52:37ZengWileyClinical and Translational Allergy2045-70222023-10-011310n/an/a10.1002/clt2.12293Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrityMichael A. Portelli0Sangita Bhaker1Vincent Pang2David O. Bates3Simon R. Johnson4Andrew P. Mazar5Dominick Shaw6Christopher Brightling7Ian Sayers8Centre for Respiratory Research NIHR Respiratory Biomedical Research Centre School of Medicine Biodiscovery Institute University Park University of Nottingham Nottingham UKCentre for Respiratory Research NIHR Respiratory Biomedical Research Centre School of Medicine Biodiscovery Institute University Park University of Nottingham Nottingham UKTumour Vascular Biology Group Biodiscovery Institute University Park University of Nottingham Nottingham UKTumour Vascular Biology Group Biodiscovery Institute University Park University of Nottingham Nottingham UKCentre for Respiratory Research NIHR Respiratory Biomedical Research Centre School of Medicine Biodiscovery Institute University Park University of Nottingham Nottingham UKDepartment of Pharmacology Feinberg School of Medicine Northwestern University Chicago Illinois USACentre for Respiratory Research NIHR Respiratory Biomedical Research Centre School of Medicine Biodiscovery Institute University Park University of Nottingham Nottingham UKDepartment of Respiratory Medicine University of Leicester University Hospitals of Leicester NHS Trust Leicester UKCentre for Respiratory Research NIHR Respiratory Biomedical Research Centre School of Medicine Biodiscovery Institute University Park University of Nottingham Nottingham UKAbstract Background Expression of the urokinase plasminogen activator receptor (uPAR) is elevated in the airway epithelium in asthma; however, the contribution of uPAR to asthma pathogenesis and scope for therapeutic targeting remains unknown. Objectives To determine (i) the expression profile of uPAR in cultured human bronchial epithelial cells (HBEC) from asthma patients, (ii) the relationship between uPAR and the epithelial barrier, including blocking uPAR functions and (iii) the function of different uPAR isoforms. Methods uPAR levels in HBECs isolated from asthma patients and cells at air liquid interface (ALI) during differentiation were quantified. Transepithelial electrical resistance or electrical cell impedance sensing was used to relate uPAR levels to barrier properties, including effects of uPAR blocking antibodies. The functional effects of gain of function was determined using transcriptomics, in cells over‐expressing membrane (muPAR), soluble cleaved (scuPAR) or soluble spliced (ssuPAR) isoforms. Results Elevated expression of uPAR was a feature of cultured HBECs from asthma patients, suggesting intrinsic alterations in asthma patient cells. Soluble uPAR levels inversely correlated with barrier properties of the HBEC layer in 2D and ALI. Blocking uPAR‐integrin interactions enhanced barrier formation. The gain of function cells showed limited transcriptomic changes. Conclusion This study provides a significant advance in our understanding of the relationship between asthma, uPAR and the epithelial barrier, where elevated circulating uPAR results in a reduced cell barrier, a phenotype prevalent in asthma.https://doi.org/10.1002/clt2.12293asthmabarrierbronchial epithelial cellsurokinase plasminogen receptor
spellingShingle Michael A. Portelli
Sangita Bhaker
Vincent Pang
David O. Bates
Simon R. Johnson
Andrew P. Mazar
Dominick Shaw
Christopher Brightling
Ian Sayers
Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity
Clinical and Translational Allergy
asthma
barrier
bronchial epithelial cells
urokinase plasminogen receptor
title Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity
title_full Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity
title_fullStr Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity
title_full_unstemmed Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity
title_short Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity
title_sort elevated plaur is observed in the airway epithelium of asthma patients and blocking improves barrier integrity
topic asthma
barrier
bronchial epithelial cells
urokinase plasminogen receptor
url https://doi.org/10.1002/clt2.12293
work_keys_str_mv AT michaelaportelli elevatedplaurisobservedintheairwayepitheliumofasthmapatientsandblockingimprovesbarrierintegrity
AT sangitabhaker elevatedplaurisobservedintheairwayepitheliumofasthmapatientsandblockingimprovesbarrierintegrity
AT vincentpang elevatedplaurisobservedintheairwayepitheliumofasthmapatientsandblockingimprovesbarrierintegrity
AT davidobates elevatedplaurisobservedintheairwayepitheliumofasthmapatientsandblockingimprovesbarrierintegrity
AT simonrjohnson elevatedplaurisobservedintheairwayepitheliumofasthmapatientsandblockingimprovesbarrierintegrity
AT andrewpmazar elevatedplaurisobservedintheairwayepitheliumofasthmapatientsandblockingimprovesbarrierintegrity
AT dominickshaw elevatedplaurisobservedintheairwayepitheliumofasthmapatientsandblockingimprovesbarrierintegrity
AT christopherbrightling elevatedplaurisobservedintheairwayepitheliumofasthmapatientsandblockingimprovesbarrierintegrity
AT iansayers elevatedplaurisobservedintheairwayepitheliumofasthmapatientsandblockingimprovesbarrierintegrity